KRT18 and obesity disorder: In the non-cirrhotic study population, a high proportion of liver disease was related to NASH/NAFLD, which exhibited an association of liver damage (CK-18) and comorbidities, e.g. obesity and hyperlipidemia, but did not show a correlation of CLDQ and CK18.